We have data on 27 companies that use BenevolentAI. The companies using BenevolentAI are most often found in United Kingdom and in the Pharmaceuticals industry. BenevolentAI is most often used by companies with 10-50 employees and 1M-10M dollars in revenue. Our data for BenevolentAI usage goes back as far as 5 years and 4 months.
If you’re interested in the companies that use BenevolentAI, you may want to check out Google Translate API and TensorFlow as well.
Company | The Goldman Sachs Group, Inc. |
Website | goldmansachs.com |
Country | United States |
Revenue | >1000M |
Company Size | >10000 |
Company | AstraZeneca PLC |
Website | astrazeneca.com |
Country | United Kingdom |
Revenue | >1000M |
Company Size | >10000 |
Company | University of Glasgow |
Website | gla.ac.uk |
Country | United Kingdom |
Revenue | >1000M |
Company Size | 5000-10000 |
Company | BioIndustry Association |
Website | bioindustry.org |
Country | United Kingdom |
Revenue | 1M-10M |
Company Size | 10-50 |
Company | Advance.org |
Website | advance.org |
Country | United States |
Revenue | 1M-10M |
Company Size | 10-50 |
Company | Website | Country | Revenue | Company Size |
---|---|---|---|---|
The Goldman Sachs Group, Inc. | goldmansachs.com | United States | >1000M | >10000 |
AstraZeneca PLC | astrazeneca.com | United Kingdom | >1000M | >10000 |
University of Glasgow | gla.ac.uk | United Kingdom | >1000M | 5000-10000 |
BioIndustry Association | bioindustry.org | United Kingdom | 1M-10M | 10-50 |
Advance.org | advance.org | United States | 1M-10M | 10-50 |
We use the best indexing techniques combined with advanced data science to monitor the market share of over 15,000 technology products, including Artificial Intelligence. By scanning billions of public documents, we are able to collect deep insights on every company, with over 100 data fields per company at an average. In the Artificial Intelligence category, BenevolentAI has a market share of about 0.1%. Other major and competing products in this category include:
BenevolentAI is creating and applying AI technologies to transform the way medicines are discovered, developed, tested and brought to market. The Company has developed the Benevolent Platform- a computational and experimental discovery platform used by BenevolentAI scientists to find new ways to treat disease and personalise drugs to patients.
Looking at BenevolentAI customers by industry, we find that Pharmaceuticals (12%) and Biotechnology (8%) are the largest segments.
60% of BenevolentAI customers are in United Kingdom and 19% are in United States.
Of all the customers that are using BenevolentAI, 49% are small (<50 employees), 12% are medium-sized and 12% are large (>1000 employees).
Of all the customers that are using BenevolentAI, a majority (57%) are small (<$50M), 15% are large (>$1000M) and 0% are medium-sized.